Cargando…
A Comparative Study on Inhibition of Total Astragalus Saponins and Astragaloside IV on TNFR1-Mediated Signaling Pathways in Arterial Endothelial Cells
BACKGROUND: Both total astragalus saponins (AST) and it’s main component astragaloside IV (ASIV) have been used in China as cardiovascular protective medicines. However, the anti-inflammatory activities that are beneficial for cardiovascular health have never been compared directly and the molecular...
Autores principales: | Liu, Qin-she, Wang, Hai-fang, Sun, An-ke, Huo, Xue-ping, Liu, Jin-lian, Ma, Shu-hui, Peng, Ning, Hu, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4081628/ https://www.ncbi.nlm.nih.gov/pubmed/24991819 http://dx.doi.org/10.1371/journal.pone.0101504 |
Ejemplares similares
-
Therapeutic effects of astragaloside IV and Astragalus spinosus saponins against bisphenol A-induced neurotoxicity and DNA damage in rats
por: Essawy, Amina E., et al.
Publicado: (2021) -
Research on the interaction of astragaloside IV and calycosin in Astragalus membranaceus with HMGB1
por: Ye, Junyi, et al.
Publicado: (2023) -
Astragalus Saponins, Astragaloside VII and Newly Synthesized Derivatives, Induce Dendritic Cell Maturation and T Cell Activation
por: Yakubogullari, Nilgun, et al.
Publicado: (2023) -
Effect of the combination of astragaloside IV and Panax notoginseng saponins on pyroptosis and necroptosis in rat models of cerebral ischemia-reperfusion
por: Tang, Biao, et al.
Publicado: (2021) -
Protective effect of Astragalus membranaceus and Astragaloside IV in sepsis-induced acute kidney injury
por: Tang, Jia-Long, et al.
Publicado: (2022)